By Bob Huff At the International AIDS Conference in Durban, South Africa, in 2000, when the movement to provide universal access to antiretroviral treatment for people with HIV around the world began in earnest, guidelines for the standard-of-care treatment of…
Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…
By Gregg Gonsalves Adapted from remarks given on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C., at a celebration for the 25th anniversary of the Multicenter AIDS Cohort Study (MACS), an ongoing prospective study of the…
A Talk with Nancy Ordover By Bob Huff Nancy Ordover, PhD, has served on the International Task Team on HIV-Related Travel Restrictions, convened by UNAIDS and concerned with issues relating to the human rights, public health, and economic impact of…
A Conversation with Sue Perez and Gregg Gonsalves By Scott W. Morgan Pressure is increasing to redirect international funding for HIV into broader health initiatives. TAG's policy director Sue Perez and international AIDS activist Gregg Gonsalves talk about these challenges…
Webcasts make CROI the most accessible AIDS conference of the year. By Bob Huff The Conference on Retroviruses and Opportunistic Infections (CROI) is the most important scientific meeting on HIV and AIDS during the year. Although attendance at CROI is…
Outbreaks of sexually transmitted hepatitis C infection have been reported among HIV-positive gay men. Early diagnosis and treatment can prevent serious liver disease, but too few doctors notice the warning signs. BY Tracy Swan A new epidemic of hepatitis…
Treatment Action Group’s response to the National Institute of Immunology and Infectious Diseases (NIAID) request for comments on the development of a research funding opportunity on HIV latency and persistence. Treatment Action Group (TAG) strongly supports reinvigorating the research…
A Conversation with Doug Richman and Celsa Spina There are only a handful scientists working on finding a cure for HIV infection. Doug Richman and Celsa Spina, from the University of California–San Diego, are among them. We asked about the…
What are the Mechanisms of HIV Latency and Persistence? The government has an extensive plan for conducting AIDS research, but finding a cure is not part of it. By Bob Huff Two of the great quests in science are to…